“There’s Always Next Year”: Primary Care Team and Parent Perspectives on the Human Papillomavirus Vaccine

References

• Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu F, Weinstock H. Sexually transmitted infections among US women and men. Sex Transm Dis. 2013;40(3):187–93. doi:10.1097/olq.0b013e318286bb53.
   PubMed Web of Science ®Google Scholar
• Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68:698–702. doi:10.15585/mmwr.mm6832a3externalicon.
   PubMed Web of Science ®Google Scholar
• Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–08. doi:10.15585/mmwr.mm6549a5.
   PubMed Web of Science ®Google Scholar
• Senkomago V, Henley SJ, ThomTias CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus–attributable cancers — United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2019;68:724–28. doi:10.15585/mmwr.mm6833a3.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:718–23. doi:10.15585/mmwr.mm6833a2.
   PubMed Web of Science ®Google Scholar
• Bratic JS, Seyferth ER, Bocchini JA. Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance. Curr Opin Pediatr. 2016;28(3):407–12. doi:10.1097/mop.0000000000000353.
   PubMed Web of Science ®Google Scholar
• Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents. JAMA Pediatr. 2014;168(1):76. doi:10.1001/jamapediatrics.2013.2752.
   PubMed Web of Science ®Google Scholar
• Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine. 2012;30(24):3546–56. doi:10.1016/j.vaccine.2012.03.063.
   PubMed Web of Science ®Google Scholar
• Radisic G, Chapman J, Flight I, Wilson C. Factors associated with parents’ attitudes to the HPV vaccination of their adolescent sons: A systematic review. Prev Med. 2017;95:26–37. doi:10.1016/j.ypmed.2016.11.019.
   PubMed Web of Science ®Google Scholar
• Loke AY, Kwan ML, Wong Y, Wong AK. The uptake of human Papillomavirus vaccination and its associated factors among adolescents: a systematic review. J Prim Care Community Health. 2017;8(4):349–62. doi:10.1177/2150131917742299.
   PubMed Web of Science ®Google Scholar
• U.S. Department of health and human services. Healthy people 2020. Immunization and infectious diseases. [accessed 2019 Jul 24]. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives
   Google Scholar
• Garbutt JM, Dodd S, Walling E, Lee AA, Kulka K, Lobb R. Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the consolidated framework for implementation research. BMC Fam Pract. 2018;19:1. doi:10.1186/s12875-018-0750-5.
   PubMed Web of Science ®Google Scholar
• Lake PW, Kasting ML, Christy SM, Vadaparampil ST. Provider perspectives on multilevel barriers to HPV vaccination. Hum Vaccin Immunother. 2019:1–10. doi:10.1080/21645515.2019.1581554.
   PubMed Web of Science ®Google Scholar
• Fernández ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2010;31(1):235–52. doi:10.1146/annurev.publhealth.012809.103609.
   PubMedGoogle Scholar
• Hudson SM, Rondinelli J, Glenn BA, Preciado M, Chao C. Human papillomavirus vaccine series completion: qualitative information from providers within an integrated healthcare organization. Vaccine. 2016;34(30):3515–21. doi:10.1016/j.vaccine.2016.02.066.
   PubMed Web of Science ®Google Scholar
• Chuang E, Cabrera C, Mak S, Glenn B, Hochman M, Bastani R. Primary care team- and clinic level factors affecting HPV vaccine uptake. Vaccine. 2017;35(35):4540–47. doi:10.1016/j.vaccine.2017.07.028.
   PubMed Web of Science ®Google Scholar
• Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s behavioral model of health services use: a systematic review of studies from 1998–2011. GMS Psycho Social Med. 2012;9:Doc11. doi:10.3205/psm000089.
   Google Scholar
• Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93. doi:10.1542/peds.2005-1381.
   PubMed Web of Science ®Google Scholar
• Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011;11(1):74. doi:10.1186/1471-2431-11-74.
   PubMed Web of Science ®Google Scholar
• Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine. 2012;30:3546–56. doi:10.1016/j.vaccine.2012.03.063.
   PubMed Web of Science ®Google Scholar
• Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, Kempe A, Dunne EF, Stokley S, Dickinson LM. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118(6):2280–89. doi:10.1542/peds.2006-1946.
   PubMed Web of Science ®Google Scholar
• Tiro JA, Pruitt SL, Bruce CM, Persaud D, Lau M, Vernon SW, Skinner CS. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012;30(13):2368–75. doi:10.1016/j.vaccine.2011.11.031.
   PubMed Web of Science ®Google Scholar
• Dedoose Version 8.0.35. web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles (CA): SocioCultural Research Consultants, LLC; 2018.
   Google Scholar
• Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: A systematic review. Hum Vaccin Immunother. 2016;12(6):1566–88. doi:10.1080/21645515.2015.1125055.
   PubMed Web of Science ®Google Scholar
• Henrikson NB, Tuzzio L, Gilkey MB, McRee A. “You’re never really off time”: healthcare providers’ interpretations of optimal timing for HPV vaccination. Preventive Med Rep. 2016;4:94–97. doi:10.1016/j.pmedr.2016.05.002.
   PubMedGoogle Scholar
• Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011;11:1. doi:10.1186/1471-2431-11-74.
   PubMed Web of Science ®Google Scholar
• Mahoney MC, Saad-Harfouche FG, Widman CA, Twarozek AM, Erwin DO, Rodriguez EM. Clinician misperceptions about the importance of adolescent HPV vaccination. World J Vaccines. 2016;6:1. doi:10.4236/wjv.2016.61002.
   Google Scholar
• Kann L, Olsen EO, McManus T, Harris WA, Shanklin SL, Flint KH, Lowry R, Chyen D, Whittle L, Thornton J, et al. Sexual identity, sex of sexual contacts, and health-related behaviors among students in grades 9–12 — United States and selected sites, 2015. MMWR Surveillance Summaries. 2016;65(9):1–202. doi:10.15585/mmwr.ss6509a1.
   Web of Science ®Google Scholar
• Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents. Arch Pediatr Adolesc Med. 2007;161(3):252. doi:10.1001/archpedi.161.3.252.
   PubMedGoogle Scholar
• Block SL, Nolan T, Sattler C, Barr E, Giacoletti KE, Marchant CD, Castellsague X, Rusche SA, Lukac S, Bryan JT. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006;118(5):2135–45. doi:10.1542/peds.2006-0461.
   PubMed Web of Science ®Google Scholar
• Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, Puchalski D, Giacoletti KED, Sings HL, Lukac S, et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents. Pediatr Infect Dis J. 2007;26(3):201–09. doi:10.1097/01.inf.0000253970.29190.5a.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34(9):1187–92. doi:10.1016/j.vaccine.2016.01.023.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, McRee A. Provider communication about HPV vaccination: A systematic review. Hum Vaccin Immunother. 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090.
   PubMed Web of Science ®Google Scholar
• Malo TL, Gilkey MB, Hall ME, Shah PD, Brewer NT. Messages to motivate human papillomavirus vaccination: national studies of parents and physicians. Cancer Epidemiol Biomarker Prev. 2016;25(10):1383–91. doi:10.1158/1055-9965.epi-16-0224.
   PubMed Web of Science ®Google Scholar
• Krantz L, Ollberding NJ, Beck AF, Carol Burkhardt M. Increasing HPV vaccination coverage through provider-based interventions. Clin Pediatr (Phila). 2017;57(3):319–26. doi:10.1177/0009922817722014.
   PubMed Web of Science ®Google Scholar
• Farmar AM, Love-Osborne K, Chichester K, Breslin K, Bronkan K, Hambidge SJ. Achieving high adolescent HPV vaccination coverage. Pediatrics. 2016;138(5):e20152653. doi:10.1542/peds.2015-2653.
   PubMed Web of Science ®Google Scholar
• Shay LA, Street RL, Baldwin AS, Marks EG, Lee SC, Higashi RT, Skinner CS, Fuller S, Persaud D, Tiro JA; Shay LA, Street RL, Baldwin AS, Marks EG, Lee SC, Higashi RT, et al. Characterizing safety-net providers’ HPV vaccine recommendations to undecided parents: A pilot study. Patient Educ Couns. 2016;99(9):1452–60. doi:10.1016/j.pec.2016.06.027.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Rand CM, McLaurin J, Tan L, Britto M, Francis A, Dunne E, Rickert D. Delivering adolescent vaccinations in the medical home: a new era? Pediatrics. 2008;121(Supplement 1):S15–S24. doi:10.1542/peds.2007-1115c.
   PubMedGoogle Scholar
• Tiro JA, Sanders JM, Pruitt SL, Stevens CF, Skinner CS, Bishop WP, Persaud D, Persaud D. Promoting HPV vaccination in safety-net clinics: a randomized trial. Pediatrics. 2015;136(5):850–59. doi:10.1542/peds.2015-1563.
   PubMed Web of Science ®Google Scholar
• Farmar AL, Love-Osborne K, Chichester K, Breslin K, Bronkan K, Hambidge SJ. Achieving high adolescent HPV vaccination coverage. Pediatrics. 2016 Nov 1;138(5):e20152653. doi:10.1542/peds.2015-2653.
   PubMed Web of Science ®Google Scholar
• Bailey HH, Chuang LT, DuPont NC, Eng C, Foxhall LE, Merrill JK, Wollins DS, Blanke CD. American society of clinical oncology statement: human papillomavirus vaccination for cancer prevention. J Clin Oncol. 2016 Apr 11;34(15):1803–12. doi:10.1200/JCO.2016.67.2014.
   PubMed Web of Science ®Google Scholar
• Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women Health. 2009;18(10):1679–86. doi:10.1089/jwh.2008.1329.
   PubMed Web of Science ®Google Scholar
• Allen JD, De Jesus M, Mars D, Tom L, Cloutier L, Shelton RC. Decision-making about the HPV vaccine among ethnically diverse parents: implications for health communications. J Oncol. 2012;(2012:1–5. doi:10.1155/2012/401979.
   Google Scholar
• Berenson AB, Laz TH, Hirth JM, McGrath CJ, Rahman M. Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9–17 years of age. Hum Vaccin Immunother. 2014;10(7):1807–11. doi:10.4161/hv.28779.
   PubMed Web of Science ®Google Scholar